Published in J Infect Dis on August 01, 1986
Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol (2001) 3.29
Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin Diagn Lab Immunol (2003) 3.27
FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications. Nat Rev Immunol (2010) 2.44
Age-related defects in CD4 T cell cognate helper function lead to reductions in humoral responses. J Exp Med (2004) 2.23
Use of highly encapsulated Streptococcus pneumoniae strains in a flow-cytometric assay for assessment of the phagocytic capacity of serotype-specific antibodies. Clin Diagn Lab Immunol (1998) 1.93
CD4 T cell memory derived from young naive cells functions well into old age, but memory generated from aged naive cells functions poorly. Proc Natl Acad Sci U S A (2003) 1.89
Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens. Infect Immun (1989) 1.86
Inflammatory cytokines overcome age-related defects in CD4 T cell responses in vivo. J Immunol (2004) 1.83
Effects of aging on T cell function. Curr Opin Immunol (2009) 1.67
Phenotypic analysis of pneumococcal polysaccharide-specific B cells. J Immunol (2012) 1.63
T-cell immunosenescence: lessons learned from mouse models of aging. Trends Immunol (2009) 1.55
Efficiency of a pneumococcal opsonophagocytic killing assay improved by multiplexing and by coloring colonies. Clin Diagn Lab Immunol (2003) 1.54
Should patients positive for HIV infection receive pneumococcal vaccine? BMJ (1995) 1.53
The effect of age on the B-cell repertoire. J Clin Immunol (2000) 1.47
Mouse antibody to phosphocholine can protect mice from infection with mouse-virulent human isolates of Streptococcus pneumoniae. Infect Immun (1992) 1.35
The effect of age on the cognate function of CD4+ T cells. Immunol Rev (2005) 1.32
Homeostasis and the age-associated defect of CD4 T cells. Semin Immunol (2005) 1.30
Use of HL-60 cell line to measure opsonic capacity of pneumococcal antibodies. Clin Diagn Lab Immunol (2005) 1.28
Quantitative relationship between anticapsular antibody measured by enzyme-linked immunosorbent assay or radioimmunoassay and protection of mice against challenge with Streptococcus pneumoniae serotype 4. Infect Immun (1990) 1.26
Use of licensed vaccines for active immunization of the immunocompromised host. Clin Microbiol Rev (1998) 1.26
Proinflammatory adjuvants enhance the cognate helper activity of aged CD4 T cells. J Immunol (2009) 1.20
Increased protection against pneumococcal disease by mucosal administration of conjugate vaccine plus interleukin-12. Infect Immun (2003) 1.19
Pneumococcal vaccination and revaccination of older adults. Clin Microbiol Rev (2003) 1.15
Immune senescence: relative contributions of age and cytomegalovirus infection. PLoS Pathog (2012) 1.13
Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults. I. Antibody concentrations, avidity and functional activity. Immun Ageing (2005) 1.09
Immunogenicity in a mouse model of a conjugate vaccine made with a synthetic single repeating unit of type 14 pneumococcal polysaccharide coupled to CRM197. Infect Immun (2002) 1.07
The effect of aging on cognate function and development of immune memory. Curr Opin Immunol (2005) 1.07
Antiphosphorylcholine antibody levels are elevated in humans with periodontal diseases. Infect Immun (1999) 1.06
Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patients. Clin Exp Immunol (1991) 1.04
Intranasal immunization with pneumococcal polysaccharide conjugate vaccines with nontoxic mutants of Escherichia coli heat-labile enterotoxins as adjuvants protects mice against invasive pneumococcal infections. Infect Immun (1999) 1.03
The effect of age on the response to the pneumococcal polysaccharide vaccine. BMC Infect Dis (2010) 1.02
Intranasal immunization with pneumococcal conjugate vaccines with LT-K63, a nontoxic mutant of heat-Labile enterotoxin, as adjuvant rapidly induces protective immunity against lethal pneumococcal infections in neonatal mice. Infect Immun (2002) 0.99
Nasal immunization with Lactococcus lactis expressing the pneumococcal protective protein A induces protective immunity in mice. Infect Immun (2008) 0.98
Enzyme-linked immunosorbent assay for measuring antibodies to pneumococcal polysaccharides for the PNEUMOVAX 23 vaccine: assay operating characteristics and correlation to the WHO international assay. Clin Vaccine Immunol (2006) 0.97
Highly reduced protection against Streptococcus pneumoniae after deletion of a single heavy chain gene in mouse. Proc Natl Acad Sci U S A (2000) 0.97
Intranasal immunization with pneumococcal polysaccharide conjugate vaccines protects mice against invasive pneumococcal infections. Infect Immun (1999) 0.96
Transplacental transmission of serotype-specific pneumococcal antibodies in a Brazilian population. Clin Diagn Lab Immunol (1999) 0.94
Age-related Deficiencies in Antigen-Specific CD4 T cell Responses: Lessons from Mouse Models. Aging Dis (2011) 0.92
Measurement and interpretation of pneumococcal IgG levels for clinical management. Clin Exp Immunol (2003) 0.92
Streptococcus pneumoniae. Thorax (1999) 0.90
Pneumococcal vaccine. Thorax (1988) 0.89
SCID-Hu mice immunized with a pneumococcal vaccine produce specific human antibodies and show increased resistance to infection. Infect Immun (1992) 0.88
Low opsonic activity to the infecting serotype in pediatric patients with invasive pneumococcal disease. Vaccine (2012) 0.85
A thymus-independent (type 1) phosphorylcholine antigen isolated from Trichinella spiralis protects mice against pneumococcal infection. Immunology (1990) 0.83
Global control of pneumococcal infections by pneumococcal vaccines. Trop Med Health (2014) 0.83
Comparative immune responses of patients with chronic pulmonary diseases during the 2-year period after pneumococcal vaccination. Clin Vaccine Immunol (2006) 0.81
Salivary antibodies induced by the seven-valent PncOMPC conjugate vaccine in the Finnish Otitis Media Vaccine Trial. BMC Infect Dis (2005) 0.80
Differential impact of ageing on cellular and humoral immunity to a persistent murine gamma-herpesvirus. Immun Ageing (2010) 0.80
Association between serotype-specific antibody response and serotype characteristics in patients with pneumococcal pneumonia, with special reference to degree of encapsulation and invasive potential. Clin Vaccine Immunol (2014) 0.80
Opsonization of Actinobacillus actinomycetemcomitans by immunoglobulin G antibody reactive with phosphorylcholine. Infect Immun (2002) 0.79
Minimal role for the spleen in antibody responses of C57BR/cdj mice to pneumococcal polysaccharide antigens. Clin Exp Immunol (1988) 0.75
Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis. PLoS Negl Trop Dis (2016) 0.75
New method for the serological grouping of Streptococci with specific antibodies adsorbed to protein A-containing staphylococci. Infect Immun (1973) 7.92
Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis (2000) 7.80
Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J (1999) 5.88
Urease. The primary cause of infection-induced urinary stones. Invest Urol (1976) 4.72
Haemophilus influenzae infections in adults: characterization of strains by serotypes, biotypes, and beta-lactamase production. J Infect Dis (1981) 3.45
Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clin Infect Dis (1999) 3.15
Ampicillin-resistant mutants of Escherichia coli K-12 with lipopolysaccharide alterations affecting mating ability and susceptibility to sex-specific bacteriophages. J Bacteriol (1971) 3.11
Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med (2000) 3.09
Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (Scarlet fever toxin). J Infect Dis (1993) 2.84
Disk diffusion susceptibility testing of Nocardia species. J Infect Dis (1977) 2.77
Severe diabetes associated with protease inhibitor therapy. Ann Intern Med (1997) 2.71
Vancomycin penetration into biofilm covering infected prostheses and effect on bacteria. J Infect Dis (1994) 2.37
Effect of human immunodeficiency virus (HIV) infection on the course of syphilis and on the response to treatment. Ann Intern Med (1990) 2.35
In vitro lymphocyte response to Treponema refringens im human syphilis. Infect Immun (1974) 2.27
Pneumonia and acute febrile tracheobronchitis due to haemophilus influenzae. Ann Intern Med (1983) 2.20
The use of protein A-containing Staphylococcus aureus as a solid phase anti-IgG reagent in radioimmunoassays as exemplified in the quantitation of alpha-fetoprotein in normal human adult serum. Eur J Immunol (1974) 2.19
Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci. Infect Immun (2001) 2.19
Lymphocyte transformation in syphilis: an in vitro correlate of immune suppression in vivo? Infect Immun (1975) 2.17
Cell-surface alterations in Escherichia coli K-12 with chromosmal mutations changing ampicillin resistance. Ann N Y Acad Sci (1971) 2.16
Clinical manifestations of halophilic non-cholera Vibrio infections. Lancet (1974) 2.14
Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus ("Streptococcus milleri group") are of different clinical importance and are not equally associated with abscess. Clin Infect Dis (2001) 2.13
Interruption of capsule production in Streptococcus pneumonia serotype 3 by insertion of transposon Tn916. Infect Immun (1990) 2.06
Spontaneous, nontraumatic gangrene due to Clostridium septicum. Rev Infect Dis (1990) 2.06
Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide. J Infect Dis (1990) 2.02
Prevention of infected urinary stones by urease inhibition. Invest Urol (1973) 2.00
Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses. Clin Infect Dis (1996) 1.98
Specific absorption of human serum albumin, immunoglobulin A, and immunoglobulin G with selected strains of group A and G streptococci. Infect Immun (1979) 1.92
Correlation of increased metabolic activity, resistance to infection, enhanced phagocytosis, and inhibition of bacterial growth by macrophages from Listeria- and BCG-infected mice. Infect Immun (1972) 1.85
Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus. Am J Med (1992) 1.81
Inhibition of the antibacterial activity of gentamicin by urine. J Infect Dis (1976) 1.78
Antibody to capsular polysaccharides of Streptococcus pneumoniae: prevalence, persistence, and response to revaccination. Clin Infect Dis (1993) 1.78
Pneumococcal virulence factors and host immune responses to them. Eur J Clin Microbiol Infect Dis (1995) 1.78
The diagnostic value of sputum culture in acute pneumonia. JAMA (1975) 1.75
An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail. N Engl J Med (1994) 1.73
Does naturally acquired IgG antibody to cell wall polysaccharide protect human subjects against pneumococcal infection? J Infect Dis (1990) 1.72
Development of bactericidal antibody during Branhamella catarrhalis infection. J Infect Dis (1985) 1.71
Bacterial spinal epidural abscess. Review of 43 cases and literature survey. Medicine (Baltimore) (1992) 1.71
Role of urease in pyelonephritis resulting from urinary tract infection with Proteus. J Infect Dis (1975) 1.71
Nonspecificity of assaying for IgG antibody to pneumolysin in circulating immune complexes as a means to diagnose pneumococcal pneumonia. Clin Infect Dis (2001) 1.70
Detection of nonspecific resistance to Listeria monocytogenes in rabbits infected with Treponema pallidum. Infect Immun (1974) 1.69
Hemophilus influenzae pneumonia in adults. Am J Med (1978) 1.69
Bacterial adherence to pharyngeal cells during viral infection. J Infect Dis (1980) 1.68
Emergence of variant forms of Staphylococcus aureus after exposure to gentamicin and infectivity of the variants in experimental animals. J Infect Dis (1977) 1.65
Opsonizing and bactericidal effects of normal human serum on nontypable Haemophilus influenzae. Infect Immun (1983) 1.62
Elution of vancomycin, daptomycin, and amikacin from acrylic bone cement. Clin Orthop Relat Res (1991) 1.59
Polymicrobial bacteremia: clinical and microbiologic patterns. Rev Infect Dis (1989) 1.59
Inhibition of bacterial urease. Invest Urol (1973) 1.57
In vitro antimicrobial effect against Streptococcus pneumoniae of adding rifampin to penicillin, ceftriaxone, or 1-ofloxacin. Antimicrob Agents Chemother (1995) 1.56
Osteomyelitis associated with pressure sores. Arch Intern Med (1994) 1.56
Testing of Streptococcus pneumoniae for resistance to penicillin. J Clin Microbiol (1993) 1.46
Amebiasis presenting as pleuropulmonary disease. West J Med (1985) 1.45
Antibiotic-induced suprainfection. J Infect Dis (1969) 1.42
Elderly patients' responses to preoperative autologous blood collection. Med J Aust (1991) 1.40
Emergence of antibody to capsular polysaccharides of Streptococcus pneumoniae during outbreaks of pneumonia: association with nasopharyngeal colonization. Clin Infect Dis (1997) 1.40
Q fever. Arch Intern Med (1988) 1.39
Characterization of the antigenic determinants and host components in immune complexes from patients with secondary syphilis. J Immunol (1986) 1.38
Phagocytosis and killing of Brucella by human polymorphonuclear leukocytes. J Infect Dis (1985) 1.35
Studies on the pathogenesis of the Jarisch-Herxheimer reaction: development of an animal model and evidence against a role for classical endotoxin. J Infect Dis (1982) 1.35
Infections due to Staphylococcus aureus. Medicine (Baltimore) (1977) 1.34
Interaction between acetohydroxamic acid and 12 antibiotics against 14 gram-negative pathogenic bacteria. Antimicrob Agents Chemother (1974) 1.32
Antibody to capsular polysaccharides of Streptococcus pneumoniae after vaccination of human immunodeficiency virus-infected subjects with 23-valent pneumococcal vaccine. J Infect Dis (1992) 1.32
Genetic regulation of the capacity to make immunoglobulin G to pneumococcal capsular polysaccharides. J Investig Med (1997) 1.29
Vertebral osteomyelitis. Still a diagnostic pitfall. Arch Intern Med (1976) 1.29
Resistance of Vibrio vulnificus to serum bactericidal and opsonizing factors: relation to virulence in suckling mice and humans. J Infect Dis (1984) 1.27
Nontypable Haemophilus influenzae are unencapsulated both in vivo and in vitro. J Infect Dis (1984) 1.27
Acute cocaine poisoning. Importance of treating seizures and acidosis. Am J Med (1983) 1.26
Hypoglycemia as a manifestation of sepsis. Am J Med (1980) 1.26
Spinal epidural abscess. Med Clin North Am (1985) 1.26
Edouard Seguin and the social power of thermometry. N Engl J Med (1987) 1.26
Suppression of phagocytosis and chemotaxis by cell wall components of Staphylococcus aureus. J Immunol (1981) 1.25
Immunoglobulin A from bronchopulmonary secretions blocks bactericidal and opsonizing effects of antibody to nontypable Haemophilus influenzae. Infect Immun (1984) 1.24
Diagnosing and treating cytomegalovirus pneumonia in patients with AIDS. Clin Infect Dis (1996) 1.24
Isotypes and opsonophagocytosis of pneumococcus type 6B antibodies elicited in infants and adults by an experimental pneumococcus type 6B-tetanus toxoid vaccine. Infect Immun (1998) 1.24
Antibiotic susceptibilities of genetically characterized Streptococcus milleri group strains. Antimicrob Agents Chemother (2001) 1.23
Aberrant secondary antibody responses to sheep erythrocytes in rabbits with experimental syphilis. Infect Immun (1979) 1.22
Permanent carriers of nontyphosa salmonellae. Arch Intern Med (1973) 1.22
Wound zygomycosis (mucormycosis) in otherwise healthy adults. Am J Med (1988) 1.22
A brief history of the pneumococcus in biomedical research: a panoply of scientific discovery. Clin Infect Dis (1993) 1.21
Protection against bacteremic pneumococcal infection by antibody to pneumolysin. J Infect Dis (2001) 1.21
Effects of BCG infection on the susceptibility of mouse macrophages to endotoxin. Infect Immun (1979) 1.21
Evaluation of immunoglobulin M western blot analysis in the diagnosis of congenital syphilis. J Clin Microbiol (1990) 1.20
Quantitative urinalysis. Diagnosing urinary tract infection in men. JAMA (1976) 1.19
The effects of growth hormone therapy in children with radiation-induced growth hormone deficiency. Acta Paediatr Scand (1981) 1.18
The immunology of syphilis. Int J Dermatol (1976) 1.18
Life-threatening Pseudomonas aeruginosa infections in patients with human immunodeficiency virus infection. Clin Infect Dis (1992) 1.18
Association between FcgammaRIIa-R131 allotype and bacteremic pneumococcal pneumonia. Clin Infect Dis (2000) 1.18